Shamon Ahmed

Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease

J. Spence, Shamon Ahmed, 2021, Biology of Sex Differences.

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Deepak L. Bhatt, Lawrence A Leiter, M. Lafreniere-Roula, 2022, Circulation.

Vitamin B12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre

V. Hachinski, L. Sposato, J. Spence, 2019, BMJ Open.

The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease

A. Yan, K. Connelly, C. Mazer, 2023, Diabetes, obesity & metabolism.

Efficacy of sodium–glucose cotransporter 2 inhibitors and angiotensin receptor–neprilysin inhibitors for heart failure in black patients: a systematic review and meta‐analysis of randomized controlled trials

B. Yanagawa, T. Yau, C. Mazer, 2023, European journal of heart failure.